or
forgot password

    • cancer clinical trials in torrington, CT

    • Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Kidney Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Colorectal Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Connecticut Oncology & Hematology - Torrington
    Torrington, Connecticut 06790
    Lung Cancer
    Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Colorectal Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Connecticut Oncology & Hematology - Torrington
    Torrington, Connecticut 06790
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Connecticut Oncology & Hematology - Torrington
    Torrington, Connecticut 06790
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Breast Cancer
    Phase II Sunitinib Prog Met AIPC
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Metastatic Prostate Cancer
    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Connecticut Oncology and Hematology LLP
    Torrington, Connecticut 06790
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Colorectal Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Breast Cancer
    Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
    Northwestern Connecticut Oncology-Hematology Associates - Torrington
    Torrington, Connecticut 06790
    Lung Cancer
    Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
    Northwestern Connecticut Oncology-Hematology Associates
    Torrington, Connecticut 06790
    Colorectal Cancer
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Northwestern Connecticut Oncology Hematology Associates, LLP
    Torrington, Connecticut 06790
    Ovarian Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Charlotte Hungerford Hospital
    Torrington, Connecticut 06790
    Non Small Cell Lung Carcinoma
    Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
    The Center for Cancer Care
    Torrington, Connecticut 06790
    Esophagitis, Pneumonitis, Non-Small Cell Lung Carcinoma
    Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
    Northwestern Connecticut Oncology - Hematology Associates
    Torrington, Connecticut 06790
    Pancreatic Cancer
    OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    Northwestern Connecticut Oncology & Hematology Associates
    Torrington, Connecticut 06790
    Pain, Cancer
    A Phase III Trial For Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph
    Torrington, Connecticut
    Breast Cancer, Breast Neoplasms, Cancer of the Breast
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Colorectal Cancer Metastatic
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Northwestern Connecticut Oncology Hematology Associates, LLP
    Torrington, Connecticut 06790
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
    Site Reference ID/Investigator# 5690
    Torrington, Connecticut 06790
    Lung Cancer, NSCLC, Non-Small-Cell Lung Cancer
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Connecticut Oncology & Hematology, LLP
    Torrington, Connecticut 06790
    Prostate Cancer
    Diarrhea Predominant Irritable Bowel Syndrome in Females
    Litchfield County Gastroenterology Associates, LLC
    Torrington, Connecticut 06790
    Irritable Bowel Syndrome
    An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
    Connecticut Oncology & Hematology
    Torrington, Connecticut 06790
    Pancreatic Cancer
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840064
    Torrington, Connecticut 06790
    Venous Thromboembolism, Cancer
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Connecticut Oncology & Hematology
    Torrington, Connecticut 06790
    Locally Recurrent or Metastatic Breast Cancer